International Patent: COMBINATIONS OF TEGAVIVINT WITH TYROSINE KINASE INHIBITORS

GENEVA, July 18 -- ITERION THERAPEUTICS INC. filed a patent application (US2026/010900) for “COMBINATIONS OF TEGAVIVINT WITH TYROSINE KINASE INHIBITORS”. With publication no. WO/2026/152064, here are the other details related to the patent application:

Kind: Initial Publication without ISR [A2]

IPC: A61K 31/445

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....